Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. The ABC Cares Foundation has created a mobile app designed to address the mental health challenges faced by construction workers. The charitable arm of Associated Builders and Contractors’ Florida East Coast chapter launched the app on Monday […]
Nonprofit launches mobile app to address industry mental health crisis Read More »
Eli Lilly on Thursday reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soared. The company’s quarterly earnings topped Wall Street estimates, but sales fell just short as Mounjaro saw lower realized prices. Zepbound and Mounjaro have now underperformed expectations for two straight
Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short Read More »
Eli Lilly on Thursday said it expects to release data from a late-stage trial on its next-generation weight loss drug retatrutide later this year, a few months earlier than anticipated. The company expects to provide results from a 68-week study in people with obesity and osteoarthritis of the knee in 2025, according to fourth-quarter earnings
Bristol Myers Squibb on Thursday reported better-than-expected quarterly results, but weak guidance for 2025 sent shares lower. Jim Cramer’s faith in the drugmaker is unshaken. Revenue in the fourth quarter rose 8% year over year to $12.34 billion, well ahead of the $11.57 billion consensus, according to analysts’ estimates compiled by LSEG. Adjusted earnings per
Bristol Myers' stock decline in response to weak guidance is a gift to investors Read More »
A recent study published in the International Journal of Cosmetic Science has shown that a topical serum containing the live probiotic Micrococcus luteus strain Q24, known as BLIS Q24, can significantly improve multiple skin health parameters. To learn more about the study and its key takeaways for cosmetics and personal care product manufacturers and suppliers,
New study confirms novel live probiotic effective in improving skin health Read More »
Global beauty insight platform BEAUTYSTREAMS has identified Adaptive Beauty as one of the biggest trends redefining inclusivity in 2025. Centering on “how developments that make beauty more accessible for specific demographics can benefit everyone,” Eleonora Mazzilli, Trend Localization & Business Development Director, North America, told CosmeticsDesign, Adaptive Beauty means crafting products and services to open
Adaptive Beauty: Meet the new standard of inclusivity in personal care Read More »
The Ride & Drive Experience returns for I&E 2025, allowing attendees to get behind the wheel of electric and alternative fuel vehicles in a real-world setting. Photo: Ross Stewart / Stewart Digital Media NAFA Fleet Management Association (NAFA) recently announced the addition of a new Indoor EV (electric vehicle) Test Track, alongside the return
NAFA Unveils New EV Test Track and Ride & Drive Experience Return at I&E 2025 Read More »
America’s Auto Auction uses a combination of organic development and strategic acquisitions to boost its service offerings and broaden its market reach. Photo: America’s Auto Auction America’s Auto Auction recently expanded into the New Jersey market by acquiring Car-Tech Auto Auction in Freehold, N.J. This move marks a milestone in the company’s
America's Auto Auction Enters New Jersey Market Read More »
Fuel cards present many benefits, from financial tracking to time saving. If you fleet uses 1,000 gallons of fule or more a month, a fuel card could be quite beneficial over using a credit card. Photo: Work Truck / Automotive Fleet Reducing fuel spending is a top concern for fleet managers, but it
Choosing a Fuel Card for Your Fleet: 6 Features to Consider Read More »
Bristol Myers Squibb on Thursday said it will slash $2 billion in costs by the end of 2027, expanding its ongoing cost-savings effort to chart a path toward long-term growth. Bristol Myers said savings will be driven by organizational changes and efforts to streamline operations, and will allow the company to invest in new science
Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance Read More »
